What is Ecovative?
Founded in 2007 by Eben Bayer and Gavin McIntyre, Ecovative operates at the intersection of biotechnology and material science. The company utilizes mycelium—the root structure of mushrooms—to grow high-performance, compostable materials that serve as direct replacements for plastic, leather, and animal-based proteins. By operating a Mycelium Foundry, Ecovative provides a scalable platform for designing and manufacturing fully formed structures that align with circular economy principles. Their market position is defined by a unique ability to scale biological production to meet enterprise-level requirements without the environmental externalities associated with traditional industrial processes.
How much funding has Ecovative raised?
Ecovative has raised a total of $71.3M across 3 funding rounds:
Debt
$350K
Series D
$60M
Other Financing Round
$11M
Debt (2020): $350K with participation from PPP
Series D (2021): $60M led by Viking Global Investors, AiiM Partners, Senator Investment Group, and Trousdale Ventures
Other Financing Round (2025): $11M supported by Advance Albany County Alliance
Key Investors in Ecovative
Viking Global Investors
Viking Global Investors is a global investment firm specializing in research-intensive, long-term focused investments using fundamental analysis to select public and private equity interests across industries and geographies.
Advance Albany County Alliance
The Advance Albany County Alliance is a Local Development Corporation dedicated to fostering business development and growth in Albany County by providing support to businesses of all sizes.
Trousdale Ventures
Trousdale Ventures is a venture capital firm that focuses on early-to-growth stage investments, providing strategic capital and operational expertise to innovative technology companies.
What's next for Ecovative?
With the recent strategic investment, Ecovative is well-positioned to scale its production capacity and expand its global network of business partners. The focus will likely shift toward optimizing the Mycelium Foundry for higher throughput and diversifying the product portfolio to penetrate new industrial verticals. As the company matures, the emphasis will remain on refining the cost-efficiency of its bio-fabricated materials to ensure they remain competitive against legacy synthetic counterparts. Future growth will be driven by the integration of their technology into global supply chains, effectively transitioning from a niche innovator to a foundational provider of sustainable industrial inputs.
See full Ecovative company page
